Escalon Medical Corp.
ESMC
$0.19
-$0.02-9.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.17% | 1.04% | 0.54% | 11.19% | -1.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.17% | 1.04% | 0.54% | 11.19% | -1.74% |
| Cost of Revenue | 1.72% | -3.45% | -4.39% | 8.85% | 2.08% |
| Gross Profit | 0.46% | 7.02% | 7.09% | 14.15% | -6.17% |
| SG&A Expenses | 5.67% | 1.56% | 1.37% | 2.31% | 5.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.62% | 0.41% | -1.43% | 5.32% | 2.42% |
| Operating Income | -194.92% | 63.13% | 227.49% | 1,801.59% | -70.27% |
| Income Before Tax | -234.61% | 24.96% | 184.27% | 1,112.58% | -72.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -234.61% | 24.96% | 184.27% | 1,112.58% | -72.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -234.61% | 24.96% | 184.27% | 1,112.58% | -72.88% |
| EBIT | -194.92% | 63.13% | 227.49% | 1,801.59% | -70.27% |
| EBITDA | -165.25% | 89.73% | 392.98% | 230,733.33% | -66.29% |
| EPS Basic | -1,239.39% | -6.32% | 104.62% | 213.00% | -94.57% |
| Normalized Basic EPS | -235.26% | 25.22% | 183.96% | 1,103.85% | -73.01% |
| EPS Diluted | -6,350.00% | 4.11% | 83.61% | 203.25% | -102.30% |
| Normalized Diluted EPS | -720.69% | -154.78% | -11.32% | 344.19% | -79.21% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 19.53% | 45.23% | 45.23% | 19.44% | -13.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |